ESR1 and cancer: While this study demonstrated that increased expression of both ERα and aromatase activate abnormal growth pathways in the mammary gland, aromatase was shown to induce a wider range of abnormalities that was associated with a higher prevalence of mammary pre-neoplasia and cancer progression [57].